Arkolith/Insider Trading/ITCI/Form 4

Mates Sharon

Chairman and CEO, DirectorIntra-Cellular Therapies, Inc. (ITCI) · full profile →Form 4 · filed Mar 10, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Tax withholding(F)10K$131.24$1.3M1.1M
Mar 10, 2025Option exercise(M)21K——1.1M
Mar 6, 2025Option exercise(M)41K——1.1M
Mar 6, 2025Tax withholding(F)20K$131.19$2.6M1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2025Option exercise(M)21K—$00
Mar 6, 2025Option exercise(M)41K—$041K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-036593) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML